Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
|3||Active, not recruiting||
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
† Study has passed its completion date and status has not been verified in more than two years.